mergersNewsغير مصنف

Insulin drug maker Mannkind explores sale -sources

NEW YORK, Jan 26 (Reuters) – Mannkind Corp, the U.S. maker of inhaled insulin drug Afrezza, is exploring strategic options, including the sale of itself, people familiar with the matter said on…

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى